BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 15002692)

  • 1. Acute aseptic meningitis as the initial presentation of a macroprolactinoma.
    Boscolo M; Baleriaux D; Bakoto N; Corvilain B; Devuyst F
    BMC Res Notes; 2014 Jan; 7():9. PubMed ID: 24398140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of cabergoline in the treatment of macroprolactinoma].
    Dupuy O; Le Marec E; Mayaudon H; Rilminger H; Bordier L; Bauduceau B
    Presse Med; 2003 Jan; 32(2):71-2. PubMed ID: 12653031
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour shrinkage and chiasmal herniation after successful cabergoline treatment for a macroprolactinoma.
    Marcos L; De Luis DA; Botella I; Hurtado A
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):126-7. PubMed ID: 11167937
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.
    Dash S; Annamalai AK; Simpson HL; Sarkies N; Antoun NM; Mannion R
    QJM; 2013 Jan; 106(1):85. PubMed ID: 22075008
    [No Abstract]   [Full Text] [Related]  

  • 5. Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.
    T'Sjoen G; Defeyter I; Van De Saffele J; Rubens R; Vandeweghe M
    J Endocrinol Invest; 2002 Feb; 25(2):172-5. PubMed ID: 11929090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cabergoline therapy for macroprolactinoma during pregnancy: a case report.
    Shahzad H; Sheikh A; Sheikh L
    BMC Res Notes; 2012 Oct; 5():606. PubMed ID: 23110890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic cure of a pituitary macroprolactinoma].
    Hurtado Amador R; Ayala AR
    Ginecol Obstet Mex; 2003 Oct; 71():522-6. PubMed ID: 15002692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Capacities of chemotherapy for pituitary tumors].
    Vaks VV; Dedov II
    Zh Vopr Neirokhir Im N N Burdenko; 2005; (2):30-6; discussion 36-7. PubMed ID: 16078633
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review.
    Behan LA; Draman MS; Moran C; King T; Crowley RK; O'Sullivan EP; Smith D; Thompson CJ; Agha A
    Pituitary; 2011 Dec; 14(4):362-6. PubMed ID: 19191028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A giant prolactinoma presenting with unilateral exophthalmos: effect of cabergoline and review of the literature.
    Berwaerts J; Verhelst J; Abs R; Appel B; Mahler C
    J Endocrinol Invest; 2000 Jun; 23(6):393-8. PubMed ID: 10908167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary apoplexy associated with cabergoline therapy.
    Chng E; Dalan R
    J Clin Neurosci; 2013 Dec; 20(12):1637-43. PubMed ID: 24113159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic macroprolactinoma mimicking a chordoma: a case report.
    Ballaux D; Verhelst J; Pickut B; De Deyn PP; Mahler C
    Endocr Relat Cancer; 1999 Mar; 6(1):117-22. PubMed ID: 10732794
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.